A detailed history of Operose Advisors LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Operose Advisors LLC holds 5,775 shares of EXAS stock, worth $343,035. This represents 0.13% of its overall portfolio holdings.

Number of Shares
5,775
Previous 5,486 5.27%
Holding current value
$343,035
Previous $231,000 70.13%
% of portfolio
0.13%
Previous 0.08%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$42.43 - $70.83 $12,262 - $20,469
289 Added 5.27%
5,775 $393,000
Q2 2023

Aug 08, 2023

SELL
$62.68 - $95.05 $11,658 - $17,679
-186 Reduced 3.28%
5,486 $515,000
Q1 2023

May 09, 2023

SELL
$47.19 - $70.77 $47,190 - $70,770
-1,000 Reduced 14.99%
5,672 $384,000
Q4 2022

Feb 13, 2023

BUY
$30.35 - $53.15 $166,500 - $291,580
5,486 Added 462.56%
6,672 $330,000
Q2 2022

Aug 11, 2022

BUY
$35.61 - $76.23 $6,623 - $14,178
186 Added 18.6%
1,186 $47,000
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $72,500 - $100,680
1,000 New
1,000 $78,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Operose Advisors LLC Portfolio

Follow Operose Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Operose Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Operose Advisors LLC with notifications on news.